Real-time molecular optical micro-imaging of EGFR mutations using a fluorescent erlotinib based tracer

BACKGROUND: EGFR mutations are routinely explored in lung adenocarcinoma by sequencing tumoral DNA. The aim of this study was to evaluate a fluorescent-labelled erlotinib based theranostic agent for the molecular imaging of mutated EGFR tumours in vitro and ex vivo using a mice xenograft model and f...

Descripción completa

Detalles Bibliográficos
Autores principales: Patout, Maxime, Guisier, Florian, Brune, Xavier, Bohn, Pierre, Romieu, Anthony, Sarafan-Vasseur, Nasrin, Sesboüé, Richard, Renard, Pierre-Yves, Thiberville, Luc, Salaün, Mathieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322267/
https://www.ncbi.nlm.nih.gov/pubmed/30612556
http://dx.doi.org/10.1186/s12890-018-0760-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322267/
https://www.ncbi.nlm.nih.gov/pubmed/30612556
http://dx.doi.org/10.1186/s12890-018-0760-z

Ejemplares similares